Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
暂无分享,去创建一个
Jun Zhu | S. Hohnloser | M. Rosenqvist | C. Granger | R. Lopes | J. Alexander | G. Flaker | S. Al‐Khatib | J. Bartunek | S. Husted | A. Hermosillo | V. Harjola | D. Vinereanu | D. Garcia | Puneet Mohan | B. Tinga